Insiders · ADCT

Peter Hug

Director at ADC Therapeutics SA (ADCT) since January 2024

Peter Hug has filed 6 insider reports with the SEC since January 2024, as director at ADC Therapeutics SA (ADCT). Peter Hug made no open-market purchases or sales in the last 12 months. The latest filing, on June 3, 2026, reports grant or award and shares withheld for taxes or exercise price at ADC Therapeutics SA (ADCT).

Filings
6
Companies
1
Bought on market
None
Sold on market
$3,448

Companies where Peter Hug is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
ADC Therapeutics SA logo
ADCT
ADC Therapeutics SA
Directorsince January 2024263,344$3,448$1.28Jun 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Hug with

Other insiders at the same companies

Questions about Peter Hug

What is Peter Hug's role at ADC Therapeutics SA?
Peter Hug reports to the SEC as director at ADC Therapeutics SA (ADCT), according to the latest filing on June 3, 2026.
How many shares does Peter Hug own?
After the latest filing that states it, Peter Hug directly owned 263,344 shares of ADC Therapeutics SA (ADCT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Hug bought or sold stock recently?
The most recent open-market sale was on June 17, 2024: sold 1,193 shares of ADC Therapeutics SA (ADCT) for $3,448 at an average of $2.89.
How do I get alerts when Peter Hug files?
Follow Peter Hug on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Hug (SEC CIK 0002000702). Totals count each trade once, skipping amendments whose original is on file, from Jan 3, 2024 on. View on SEC EDGAR · Get this as JSON